histidine has been researched along with Carcinoma, Lewis Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fink, A; Makovitzki, A; Shai, Y | 1 |
Birsner, AE; Folkman, J; Javaherian, K; Ramanujam, VM; Satchi-Fainaro, R; Tjin Tham Sjin, RM | 1 |
2 other study(ies) available for histidine and Carcinoma, Lewis Lung
Article | Year |
---|---|
Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.
Topics: Adenocarcinoma; Animals; Carcinoma, Lewis Lung; Cell Growth Processes; Cell Line, Tumor; Histidine; Humans; Hydrogen-Ion Concentration; Lysine; Male; Mice; Mice, Nude; NIH 3T3 Cells; Oligopeptides; Prostatic Neoplasms; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2009 |
A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity.
Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Carcinoma, Lewis Lung; Cell Movement; Endostatins; Endothelial Cells; Histidine; Humans; Mice; Mice, Inbred C57BL; Mice, SCID; Molecular Sequence Data; Pancreatic Neoplasms; Peptide Fragments; Protein Conformation; Protein Structure, Tertiary; Structure-Activity Relationship; Xenograft Model Antitumor Assays; Zinc | 2005 |